§ 2500-a. Test for phenylketonuria and other diseases and conditions.
1. It shall be the duty of the administrative officer or other person in
charge of each institution caring for infants twenty-eight days or less
of age and the person required in pursuance of the provisions of section
forty-one hundred thirty of this chapter to register the birth of a
child, to cause to have administered to every such infant or child in
its or his care a test for diseases and conditions designated by the
commissioner under regulations of the commissioner, and for:

(a) Phenylketonuria.

(b) Homozygous sickle cell disease.

(c) Hypothyroidism.

(d) Branched-chain ketonuria.

(e) Galactosemia.

(f) Homocystinuria.

(g) Critical congenital heart defects through pulse oximetry
screening.

(h) With regard to any newborn infant who is identified as, or
suspected of, having a hearing impairment as a result of a screening
conducted pursuant to section twenty-five hundred-g of this title, a
urine polymerase chain reaction (PCR) test for cytomegalovirus, unless
the parent of the infant objects thereto; provided that if the
commissioner determines that another test for cytomegalovirus is
diagnostically equivalent to or better than the urine polymerase chain
reaction test, the commissioner may, by regulation under this section,
allow or require the use of that other test.

(i) Adrenoleukodystrophy.

(j) Glucose-6-phosphate dehydrogenase deficiency using a quantitative
enzymatic test or other diagnostic test in cases where: the newborn
infant presents with hemolytic anemia, hemolytic jaundice, or
early-onset increasing neonatal jaundice, that is, jaundice (bilirubin
level greater than fortieth percentile for age in hours) persisting
beyond the day of birth through the week after birth; the newborn infant
has been admitted to the hospital for jaundice following birth; or the
biological parent of the newborn infant indicates a family, racial, or
ethnic risk of glucose-6-phosphate dehydrogenase deficiency, including
having significant African, Asian, Mediterranean, or Middle Eastern
ancestry.

(k) Duchenne muscular dystrophy using a test validated by the
Wadsworth center for laboratories and research.

2. Testing, the recording of the results of such tests, tracking,
follow-up reviews and educational activities shall be performed at such
times and in such manner as may be prescribed by the commissioner. The
commissioner shall promulgate regulations setting forth the manner in
which information describing the purposes of the requirements of this
section shall be disseminated to parents or a guardian of the infant
tested.

3. The provisions of this section shall not apply in the case of any
infant or child whose parent or guardian is a member of a recognized
religious organization whose teachings and tenets are contrary to the
testing herein required and who notifies the person charged with having
such test administered of his objection thereto.